article thumbnail

Global Healthcare Industry – M&A and Capital Market Landscape Update

Evalueserve

On the other hand, Biotech heavily underperformed post Q1’21 primarily due to the shifting of focus towards cyclicals and negative sentiments arising as of result of greater regulatory clampdown on transformative deals and drug pricing. Global Healthcare Capital Markets Activity. Healthcare Funding – Normalization of ‘Cash Runways’.

Capital 98
article thumbnail

Slow Start to Venture Capital Funding in 2024

Alpha Sense BI

The venture capital landscape continues to test the discipline and diligence of investors and startups alike. Like many other asset classes, venture capital continues to be impacted by lingering macroeconomic factors affecting funding and liquidity prospects. Interest rates are high.

Capital 69
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Venture Capital Trends and Outlook for 2024

Alpha Sense BI

Heading into the second half of 2024, venture capital investors remain cautious as they acknowledge persistent challenging dynamics in the landscape. While dry powder reserves have reached record highs, investors are wary about deploying capital with certain recent macroeconomic factors still fresh in mind.

Capital 52
article thumbnail

5 Top VCs For Data Startups

IT Business Edge

It seems that the boom times for venture capital are over. Here we’ll look at five of the top venture capital firms for data – along with some insight into where they see current investment opportunities. Sequoia is one of the pioneers of the venture capital industry. Just look at Sequoia. and Google. billion).

Startups 101
article thumbnail

Key Takeaways from J.P. Morgan’s 41st Annual Healthcare Conference?

Alpha Sense BI

Attracting industry leaders, emerging fast-growth companies, and technology creators from around the world, life science corporations share their latest advances, leading research, and best practices — as well as their intentions to scale their digital health solutions — to the masses in hopes of securing capital.

Biotech 96
article thumbnail

Vaccine Development: What to Expect in 2023

Alpha Sense BI

Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital. a potential cure for skin cancer.

Biotech 96
article thumbnail

Owler Weekly Funding Insights June 5-11, 2023

Owler

The funding round was led by venture capital firm Andreessen Horowitz. in Funding Founded in 2014, venture capital firm Swanlaab Venture Factory says it, “aims to invest in early-stage Spanish startups with B2B business models and clear technological differentiation.” Swanlaab Venture Factory Receives $48.1M

Biotech 52